Amgen
AMGN
#81
Rank
$164.06 B
Marketcap
$305.84
Share price
-0.22%
Change (1 day)
40.99%
Change (1 year)

The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.

Amgen (AMGN) - Total debt

Total debt on the balance sheet as of March 2024 : $64.02 B

According to Amgen's latest financial reports the company's total debt is $64.02 B. A companyโ€™s total debt is the sum of all current and non-current debts.

Amgen - Total debt on balance sheet (from 2001 to 2024)

Total debt by year

Year Total debt Change
2023-12-31$64.61 B65.91%
2022-12-31$38.94 B16.92%
2021-12-31$33.30 B0.98%
2020-12-31$32.98 B10.31%
2019-12-31$29.90 B-11.87%
2018-12-31$33.92 B-4%
2017-12-31$35.34 B2.16%
2016-12-31$34.59 B10.08%
2015-12-31$31.42 B2.32%
2014-12-31$30.71 B-4.4%
2013-12-31$32.12 B21.11%
2012-12-31$26.52 B23.81%
2011-12-31$21.42 B60.37%
2010-12-31$13.36 B26.04%
2009-12-31$10.60 B4.18%
2008-12-31$10.17 B-8.96%
2007-12-31$11.17 B24.02%
2006-12-31$9.01 B127.75%
2005-12-31$3.95 B-22.56%
2004-12-31$5.11 B65.91%
2003-12-31$3.08 B-2.87%
2002-12-31$3.17 B882.04%
2001-12-31$0.32 B

Total debt for similar companies or competitors

Company Total debt differencediff. Country
$33.63 B-47.47%๐Ÿ‡บ๐Ÿ‡ธ USA
$68.70 B 7.32%๐Ÿ‡บ๐Ÿ‡ธ USA
$74.00 B 15.59%๐Ÿ‡บ๐Ÿ‡ธ USA
$26.21 B-59.06%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.94 B-89.15%๐Ÿ‡บ๐Ÿ‡ธ USA
$25.19 B-60.65%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.27 B-96.44%๐Ÿ‡บ๐Ÿ‡ธ USA
$57.40 B-10.33%๐Ÿ‡บ๐Ÿ‡ธ USA
$22.45 B-64.92%๐Ÿ‡ฌ๐Ÿ‡ง UK